IITRI BLOG
Blog
We are ready to answer your questions and provide guidance.
IITRI Blog
American College of Toxicology 40th Annual Meeting
American College of Toxicology 40th Annual Meeting Booth #208 November 17-20, 2019 Phoenix, AZ Meet with our Business Development and Toxicology leadership at the 40th Annual Meeting of the American College of Toxicology. Learn about our capabilities in...
World Vaccine & Immunotherapy Congress
World Vaccine & Immunotherapy Congress Booth #15 December 2-5, 2019 San Francisco, CA Stop by to talk to us about your vaccine or immunotherapy development to learn how we can move your program forward to in vivo studies and clinical use. IITRI has over 15 years...
2020 ASM Biothreats
2020 ASM Biothreats January 28-30, 2020 Arlington, VA
Dave McCormick at Science2Startup: New Sleep Apnea Drugs
David McCormick has been selected to present on the development of novel agents to treat sleep-disordered breathing (SDB; sleep apnea) at the invitation-only Science2Startup (S2S)™ symposium on April 23, 2019, in Cambridge. The presenting group of 12 was...
IITRI-Vaccine-Antiinfectives-Lunch-n-Learn
IITRI-Vaccine-Antiinfectives-Lunch-n-Learn Title: Regulatory Approval Pathways for Vaccines and Antivirals: Laying the Groundwork Location: MassBio, 300 Technology Square, 8th Floor, Cambridge MA, 02139 Date/Time: Tuesday, September 25, 2018 Registration: 11 am...
Zika Poster Presentation at ASM Biothreats 2018 Meeting
IITRI will be presenting a poster at the ASM Biothreats 2018 Meeting, February 12-14 in Baltimore, MD. For more details, please contact us. Title: Humoral and cellular immune dynamics following Zika virus secondary challenge in non-human primates. Authors: J. M....
Dave McCormick Presenting at Eurotox 2017
Dave McCormick, IITRI's Director, will be presenting at Eurotox 2017 in a symposium session: Toxicology and Cellular Mechanisms of Electromagnetic Fields (EMF) – Health Aspects of Exposure to EMF Emitted by Wireless Mobile Systems and Emerging Technologies. His talk...
Expansion of ABSL-3 NHP Capacity at IITRI
IITRI now has expanded animal biosafety level 3 (ABSL-3) capacity to conduct pathogen challenge studies for vaccines or therapeutics in non-human primates (NHPs). Our ABSL-3 laboratories include head-only aerosol infection by inhalation exposure and plethysmography...
Zika Virus (ZIKV) Mouse Pregnancy Model Now Available
A mouse pregnancy model is now available from IITRI to evaluate the ability of vaccines or antivirals for protection against Zika virus (ZIKV) maternal-fetal viral transmission and resulting fetal defects such as microcephaly. Details of this mouse model and its use...
IITRI Announces New Flow Cytometry Services
IITRI is pleased to announce the addition of immunophenotyping services using flow cytometry to our ex vivo assay offerings. In flow cytometry, multiple properties can be analyzed simultaneously at the single cell level by generating a stream of cells in single-file...
Recent Comments